Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial

Overview of attention for article published in Pediatrics, January 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy: 1 policy source
patent: 1 patent

f1000: 1 research highlight platform

Citations

dimensions_citation: 186 Dimensions

Readers on

mendeley: 171 Mendeley
citeulike: 1 CiteULike

Summary Policy documents Patents Research highlights Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Compositions and methods related to inhibition of respiratory syncytial virus entry

Grant US-10765754-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.